Correlation Between Viridian Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Pliant Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Viridian and Pliant is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Pliant Therapeutics. In addition to that, Viridian Therapeutics is 1.15 times more volatile than Pliant Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest 1,421 in Pliant Therapeutics on August 24, 2024 and sell it today you would lose (136.00) from holding Pliant Therapeutics or give up 9.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Pliant Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Pliant Therapeutics |
Viridian Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |